Is Lybalvi (olanzapine/samidorphan) 5‑10 mg equivalent to olanzapine 2.5 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lybalvi 5-10 mg is NOT equivalent to olanzapine 2.5 mg

Lybalvi 5 mg/10 mg contains 5 mg of olanzapine (not 2.5 mg), combined with 10 mg of samidorphan—these are fundamentally different medications with different dosing paradigms. The "5-10" designation refers to 5 mg olanzapine plus 10 mg samidorphan, not a 2.5 mg olanzapine dose 1.

Understanding Lybalvi Formulations

Lybalvi is available in four fixed-dose combinations 1:

  • 5 mg/10 mg = 5 mg olanzapine + 10 mg samidorphan
  • 10 mg/10 mg = 10 mg olanzapine + 10 mg samidorphan
  • 15 mg/10 mg = 15 mg olanzapine + 10 mg samidorphan
  • 20 mg/10 mg = 20 mg olanzapine + 10 mg samidorphan

The samidorphan component is fixed at 10 mg across all formulations—only the olanzapine dose varies 1.

Clinical Dosing Context

For schizophrenia, the recommended starting dose is either 5 mg/10 mg or 10 mg/10 mg, with therapeutic dosing ranging from 10-20 mg/10 mg 1. The 5 mg/10 mg starting dose is specifically reserved for patients with:

  • Predisposition to hypotensive reactions
  • Potential for slower olanzapine metabolism
  • Greater pharmacodynamic sensitivity to olanzapine 1

There is no 2.5 mg olanzapine formulation in Lybalvi—the lowest available olanzapine dose is 5 mg 1.

Key Pharmacologic Distinction

Lybalvi is not simply "low-dose olanzapine." The samidorphan component functions as a mu-opioid receptor antagonist designed to mitigate olanzapine-induced weight gain while preserving antipsychotic efficacy 2, 3, 4. In clinical trials, olanzapine/samidorphan demonstrated 37% lower weight gain compared to olanzapine alone while maintaining equivalent antipsychotic efficacy 4.

Critical Safety Considerations

Samidorphan's opioid antagonist properties create absolute contraindications 1:

  • Patients currently using opioids (risk of precipitated withdrawal)
  • Patients in acute opioid withdrawal
  • Requires 7-day opioid-free interval from short-acting opioids or 14-day interval from long-acting opioids before initiation

Recent real-world data identified 31 cases of precipitated opioid withdrawal, with some requiring intubation and withdrawal lasting approximately 24 hours 5. This is a critical screening requirement before prescribing.

Bottom Line

If you need a 2.5 mg olanzapine dose, you must use standard olanzapine formulations—Lybalvi cannot be divided or combined to achieve this dose 1. The lowest Lybalvi formulation delivers 5 mg of olanzapine with mandatory 10 mg samidorphan co-administration.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.